Isozyme-selective cyclic nucleotide phosphodiesterase inhibitors: biochemistry, pharmacology and therapeutic potential in asthma

Prog Drug Res. 1993:40:9-32. doi: 10.1007/978-3-0348-7147-1_3.

Authors

D Raeburn¹, J E Souness, A Tomkinson, J A Karlsson

Affiliation

¹ Rhône-Poulenc Rorer Ltd., Dagenham Research Centre, Dagenham, Essex, England.

PMID: 8395068
DOI: 10.1007/978-3-0348-7147-1_3

No abstract available

Publication types

Review

MeSH terms

2',3'-Cyclic-Nucleotide Phosphodiesterases / antagonists & inhibitors*
2',3'-Cyclic-Nucleotide Phosphodiesterases / physiology
Animals
Anti-Inflammatory Agents / pharmacology
Asthma / drug therapy*
Binding Sites
Humans
Isoenzymes / antagonists & inhibitors*
Isoenzymes / physiology
Phosphodiesterase Inhibitors / pharmacology*
Phosphodiesterase Inhibitors / therapeutic use
Vasodilator Agents / pharmacology

Substances

Anti-Inflammatory Agents
Isoenzymes
Phosphodiesterase Inhibitors
Vasodilator Agents
2',3'-Cyclic-Nucleotide Phosphodiesterases